127 related articles for article (PubMed ID: 38583909)
1. Clinical influence of prophylactic lateral lymph node dissection on oncologic outcomes of patients with mid-low rectal cancer undergoing mesorectal excision: a meta-analysis.
Ishizuka M; Shibuya N; Hachiya H; Nishi Y; Takayanagi M; Fujita J; Ihara K; Shiraki T; Matsumoto T; Mori S; Iso Y; Nakamura T; Aoki T; Irisawa A
J Gastrointest Surg; 2024 Apr; 28(4):548-558. PubMed ID: 38583909
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
Tsukamoto S; Fujita S; Ota M; Mizusawa J; Shida D; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Tsuchida A; Okamura S; Akagi Y; Takiguchi N; Saida Y; Akasu T; Moriya Y;
Br J Surg; 2020 Apr; 107(5):586-594. PubMed ID: 32162301
[TBL] [Abstract][Full Text] [Related]
3. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
Kroon HM; Hoogervorst LA; Hanna-Rivero N; Traeger L; Dudi-Venkata NN; Bedrikovetski S; Kusters M; Chang GJ; Thomas ML; Sammour T
Eur J Surg Oncol; 2022 Jul; 48(7):1475-1482. PubMed ID: 35568607
[TBL] [Abstract][Full Text] [Related]
5. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
[TBL] [Abstract][Full Text] [Related]
6. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y;
Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
[TBL] [Abstract][Full Text] [Related]
7. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
[TBL] [Abstract][Full Text] [Related]
8. Is prophylactic lateral lymph node dissection needed for lower rectal cancer? A single-center retrospective study.
Kondo H; Yamaguchi S; Hirano Y; Aikawa M; Sato H; Okamoto K; Sakuramoto S; Koyama I
BMC Surg; 2021 May; 21(1):261. PubMed ID: 34039328
[TBL] [Abstract][Full Text] [Related]
9. Rise and fall of total mesorectal excision with lateral pelvic lymphadenectomy for rectal cancer: an updated systematic review and meta-analysis of 11,366 patients.
Anania G; Davies RJ; Arezzo A; Bagolini F; D'Andrea V; Graziosi L; Di Saverio S; Popivanov G; Cheruiyot I; Cirocchi R; Donini A
Int J Colorectal Dis; 2021 Nov; 36(11):2321-2333. PubMed ID: 34125269
[TBL] [Abstract][Full Text] [Related]
10. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
[TBL] [Abstract][Full Text] [Related]
11. Oncological outcomes of lateral lymph node dissection (LLND) for locally advanced rectal cancer: is LLND alone sufficient?
Ishibe A; Watanabe J; Suwa Y; Suzuki S; Nakagawa K; Suwa H; Ozawa M; Ota M; Fujii S; Ike H; Ichikawa Y; Endo I
Int J Colorectal Dis; 2021 Feb; 36(2):293-301. PubMed ID: 32965528
[TBL] [Abstract][Full Text] [Related]
12. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis].
Shi FY; Zhang L; Qin Q; Jin X; Hu CH; Yu TY; Ma L; Wang GH; Wu H; Xia P; Sun XJ; She JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):370-376. PubMed ID: 32306605
[No Abstract] [Full Text] [Related]
13. Short- and long-term outcomes of laparoscopic versus open lateral lymph node dissection for locally advanced middle/lower rectal cancer using a propensity score-matched analysis.
Watanabe J; Ishibe A; Suwa Y; Ozawa M; Nakagawa K; Suwa H; Ota M; Kunisaki C; Endo I
Surg Endosc; 2021 Aug; 35(8):4427-4435. PubMed ID: 32875413
[TBL] [Abstract][Full Text] [Related]
14. Two-team lateral lymph node dissection assisted by the transanal approach for locally advanced lower rectal cancer: comparison with the conventional transabdominal approach.
Narihiro S; Kitaguchi D; Ikeda K; Hasegawa H; Teramura K; Tsukada Y; Nishizawa Y; Ito M
Surg Endosc; 2023 Jul; 37(7):5256-5264. PubMed ID: 36973567
[TBL] [Abstract][Full Text] [Related]
15. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
[TBL] [Abstract][Full Text] [Related]
16. Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis.
Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q;
Jpn J Clin Oncol; 2023 Jan; 53(1):26-34. PubMed ID: 36354102
[TBL] [Abstract][Full Text] [Related]
17. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
[TBL] [Abstract][Full Text] [Related]
18. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the short-term surgical outcomes of lateral lymph node dissection for low rectal cancer using a robotic-assisted transabdominal approach alone or supported by a transanal approach.
Tokunaga T; Kashihara H; Yoshikawa K; Nakao T; Nishi M; Takasu C; Wada Y; Yoshimoto T; Shimada M
Surg Endosc; 2024 Apr; 38(4):2070-2077. PubMed ID: 38438675
[TBL] [Abstract][Full Text] [Related]
20. Open versus laparoscopic lateral lymph node dissection for mid- and low- rectal cancer: a propensity score matching study.
Zhang Y; Yang X; Wang D; Zhuang Z; Wei M; Meng W; Deng X; Wang Z
ANZ J Surg; 2021 Nov; 91(11):2487-2492. PubMed ID: 34664380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
